UK health authorities have identified 77 cases of a new CCP virus variant first identified in India, which has two mutations that may contribute to increased transmissibility and resistance to vaccines.
The variant was first seen in two Indian states at the end of 2020, and since then has accounted for an increasing proportion of COVID-19 cases in the country, said Dr. Maria Van Kerkhove, COVID-19 Technical lead at the World Health Organization’s (WHO) Health Emergencies Programme.
Van Kerkhove said the Indian variant has two mutations—E484Q and L452R—which have been seen in other variants around the world.
The presence of these two mutations is “concerning,” she said, because “there’s a similarity in these mutations that confer increased transmissibility, for example, and some of these mutations also result in reduced neutralisation, which may have an impact on our countermeasures, including the vaccines.”
The UK government currently carrying out surge testing operations in London and in the Midlands in an attempt to curb the spread of the CCP virus variant first identified in South Africa, which is also believed to be more resistant to antibodies than the old variant.
Everybody aged 16 years and over who resides or works in these areas is “strongly encouraged” to take a PCR test, whether they are showing symptoms or not, the DHSC said.
Latest official data show 600 cases have been found in the UK, with an increase of 56 over the past week.